Speaker
Haifa Shen, MD, PhD
Date
Location
University of Houston
Abstract
There exist multiple physical and biological barriers that prohibit effective entry of
therapeutic agents into the tumor tissue, rendering most treatment ineffective.
Consequently, new cancer therapeutic agents should be empowered with the ability to
negotiate with such barriers both at the systemic level and inside the tumor tissue. In the
presentation, I am going to describe a number of enabling technology platforms for cancer
drug design.
therapeutic agents into the tumor tissue, rendering most treatment ineffective.
Consequently, new cancer therapeutic agents should be empowered with the ability to
negotiate with such barriers both at the systemic level and inside the tumor tissue. In the
presentation, I am going to describe a number of enabling technology platforms for cancer
drug design.